Taisho to buy Bristol-Myers' Asia rights.

Taisho to buy Bristol-Myers' Asia rights.

Taisho Pharmaceutical (4535.T) said it will pay $310 million for the rights to Bristol-Myers Squibb's (BMY.

Full Story